Vontobel Asset Management Inc. decreased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.2% during the fourth quarter, HoldingsChannel reports. The firm owned 1,595,122 shares of the healthcare conglomerate’s stock after selling 3,063 shares during the period. UnitedHealth Group makes up approximately 2.6% of Vontobel Asset Management Inc.’s holdings, making the stock its 13th biggest holding. Vontobel Asset Management Inc.’s holdings in UnitedHealth Group were worth $361,210,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Capital International Investors raised its position in UnitedHealth Group by 399.3% during the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares in the last quarter. Jennison Associates LLC raised its position in UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC raised its position in UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. raised its position in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. Finally, Parametric Portfolio Associates LLC raised its position in UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares in the last quarter. Institutional investors and hedge funds own 85.65% of the company’s stock.
Shares of UnitedHealth Group Inc (UNH) opened at $229.37 on Tuesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. The firm has a market capitalization of $221,952.83, a P/E ratio of 21.42, a price-to-earnings-growth ratio of 1.34 and a beta of 0.70. UnitedHealth Group Inc has a 12-month low of $156.49 and a 12-month high of $250.79.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the firm posted $2.11 EPS. equities research analysts anticipate that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.31%. UnitedHealth Group’s payout ratio is 28.01%.
In other news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the sale, the director now directly owns 36,989 shares in the company, valued at $8,218,955.80. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 53,396 shares of company stock worth $12,262,067. Insiders own 0.89% of the company’s stock.
Several research firms have recently commented on UNH. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Evercore ISI reiterated an “outperform” rating and issued a $255.00 price objective (up previously from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective on the stock in a report on Saturday, January 20th. Finally, ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $243.22.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.